Cardiology: Happitech Founder Yosef Harb of on Scaling AFib Monitoring Through Smartphones

AFib affects nearly 60 million people worldwide, yet millions remain undiagnosed until it’s too late. In this episode, Yosef Safi Harb of Happitech joins Omar Khateeb to share how his team is making large-scale, accessible cardiac monitoring possible through smartphone technology and AI. From clinical studies in Europe to upcoming FDA submissions, we explore what it takes to bring a software-as-a-medical-device to market.Episode Breakdown:00:00 Why AFib can be deadly even in healthy people01:10 The global AFib burden and why it matters02:00 Introducing Yosef Safi Harb and Happitech03:01 Yosef’s background in the Netherlands and Lebanon04:27 From aerospace engineering to medtech05:26 Family experience with AFib and founding Happitech06:00 What atrial fibrillation is and why it’s dangerous07:21 How AFib leads to stroke risk09:29 Lifestyle and comorbidities that contribute to AFib11:05 Different types of AFib explained12:03 Hypertension and why AFib is a downstream risk12:28 Traditional AFib monitoring methods and their limits14:03 Why wearables don’t reach most patients14:46 Happitech’s approach: accessible, scalable phone-based monitoring16:02 How the technology works on any smartphone18:07 Accessibility vs scalability and why smartphones win19:12 Embedding monitoring in clinical workflows20:32 Study results: detecting more AFib and reducing readmissions21:21 Regulatory pathway and FDA submission plans22:27 Clinical studies and validation outcomes in Europe23:43 Large-scale Netherlands study screening 160,000 people24:46 Business model: following the medical device playbook25:49 Why cybersecurity is critical for digital medtech26:47 Scaling in the US and upcoming focus markets27:09 Conferences where you can meet Happitech28:03 Closing reflections and call to action for clinicians and investorsAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channel⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Subscribe to our LinkedIn Newsletter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow The State of MedTech onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠⁠⁠This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#Medtech #AFib #HealthcareInnovation #Cardiology #AIinHealthcare #StateofMedTech #MedicalDevices